Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
RecruitingNCT07670468
LucasBioBKV Infection, CMV Infection, EBV Infection
Start: 2025-12-04End: 2027-06-04Target: 27Updated: 2026-06-26